You're reading the free version. Trader adds the live tape and alerts.
Start tracking
LYEL Sale Disclosure
Lee Gary K. · SEC Form 4 · Filed Aug 25, 2026
Sale
Calculated transaction value
$22.64K
Lee Gary K. Chief Scientific Officer
LYEL
Lyell Immunopharma
LYEL
Transaction date
Aug 21, 2026
Public filing date
Aug 25, 2026
Filing lag
Filed 4 days later
LYEL daily price context
Close on/before transaction
$15.53
Aug 21, 2026
First close after public filing
$14.8
Aug 26, 2026
30-day return after filing
-31.62%
Through Sep 24, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,457 shares @ $15.54
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001907345-26-000006
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$22.64K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Lyell Immunopharma, Inc. LYEL Current | Sale | Aug 21, 2026 | $22.64K |